IAPP and migraine disorder: The canonical focus on CGRP in migraine expanded to include amylin when it was discovered that 2 s-generation gepants antagonized both the CGRP receptor and amylin 1 (AMY1) receptor, the latter of which has been shown to be stimulated by CGRP and amylin with equal potency in vitro (63–65).